10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: The HyRAS study

BMC Pregnancy and Childbirth

Volumn 10, Issue , 2010, Pages

  Hermes, Wietske ^a,b   Franx, Arie ^c   van Pampus, Maria G ^d   Bloemenkamp, Kitty W ^b   van der Post, Joris A ^e   Porath, Martina ^f   Ponjee, Gabrielle ^a   Tamsma, Jouke T ^b   Mol, Ben W ^e   de Groot, Christianne J ^a  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Sint Elisabeth Hospital Tilburg   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD BEHAVIOR CHECKLIST; COHORT ANALYSIS; COST BENEFIT ANALYSIS; FEMALE; GLUCOSE METABOLISM; HIGH RISK POPULATION; HUMAN; MATERNAL HYPERTENSION; MOTOR DEVELOPMENT; NERVOUS SYSTEM DEVELOPMENT; PREECLAMPSIA; PRIMARY PREVENTION; RISK ASSESSMENT; SCREENING; SINGLE NUCLEOTIDE POLYMORPHISM; CAUSE OF DEATH; MASS SCREENING; NETHERLANDS; ORGANIZATION AND MANAGEMENT; PREDICTION AND FORECASTING; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL MODEL; THIRD TRIMESTER PREGNANCY;

CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LOGISTIC MODELS; MASS SCREENING; NETHERLANDS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS;

EID: 77952794265     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-10-28     Document Type: Article

References (17)

1. RIVM. 2007, , http://www.rivm.nl/vtv/object_document/o2305n18837.html
2. Schuitemaker NEW, van Roosmalen J, Dekker GA, van Dongen P, van Geijn H, Bennebroek Gravenhorst J. Confidential enquiry into maternal deaths in the Netherlands 1983-1992. Eur J Obstet Gynecol Reprod Biol 1998, 79:57-62. 10.1016/S0301-2115(98)00053-0, 9643405.
3. Baha M, Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003, 102:181-192. 10.1016/S0029-7844(03)00475-7, 12850627.
4. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, van den Berg PP, de Boer K, Burggraaff JM, Bloemenkamp KW, Drogtrop AP, Franx A, de Groot CJM, Huisjes AJ, Kwee A, van Loon AJ, Lub A, Papatsonis DN, van der Post JA, Roumen FJ, Scheepers HC, Willekes C, Mol BW, van Pampus MG, . HYPITAT study group Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009, 374:979-88. 10.1016/S0140-6736(09)60736-4, 19656558, HYPITAT study group.
5. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 2002, 325:157-160. 10.1136/bmj.325.7356.157, 1123678, 12130616.
6. Ramsay JE, Stewart F, Green IA, Sattar N. Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG 2003, 110:1029-1031. 10.1111/j.1471-0528.2003.02069.x, 14592589.
7. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, Smith WC. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003, 326:1-7.
8. Haukkamaa L, Salminen M, Laivuori H, Leinonen H, Hiilesmaa V, Kaaja R. Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 2004, 93:805-808. 10.1016/j.amjcard.2003.11.065, 15019902.
9. Smith GCS, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births. Lancet 2001, 357:2002-2006. 10.1016/S0140-6736(00)05112-6, 11438131.
10. Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001, 323(7323):1213-7. 10.1136/bmj.323.7323.1213, 59993, 11719411.
11. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfússon N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995, 74:772-6. 10.3109/00016349509021195, 8533558.
12. Manten GTR, Sikkema JM, Voorbij HAM, Visser GHA, Bruinse HW, Franx A. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Pregnancy as a challenge test for future cardiovascular disease. Hypertens Pregnancy 2007, 26:39-50. 10.1080/10641950601146574, 17454217.
13. Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension 2003, 42(1):39-42. 10.1161/01.HYP.0000074428.11168.EE, 12743016.
14. van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006, 195(3):723-728. 10.1016/j.ajog.2006.06.044, 16949403.
15. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
16. Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, Holden A, De Bacquer D, Collier T, De Backer G, Faergeman O, . EUROACTION Study Group Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008, 371(9629):1999-201. 10.1016/S0140-6736(08)60868-5, 18555911, EUROACTION Study Group.
17. van Rijn BB. Early-onset preeclampsia: Constitutional factors and consequences for future pregnancy outcome and cardiovascular health. PhD thesis 2008, Utrecht University.